Estimating the Impact of Self-Management Education, Influenza Vaccines, Nebulizers, and Spacers on Health Utilization and Expenditures for Medicaid-Enrolled Children with Asthma.

CONCLUSIONS: Promoting asthma self-management education, influenza vaccinations, nebulizers, and spacers can decrease the frequency of healthcare utilization and asthma-related expenditures while improving medication adherence. PMID: 33031709 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research

Related Links:

cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4743798","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Flu Vaccine Source Type: news
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Magazine Source Type: news
Authors: Erat T, Özdemir H, Taşkınoğlu T, İnce E, Çiftçi E Abstract Influenza is an important cause of respiratory illness in children and is still an important cause of morbidity and mortality in children. The influenza virus subtypes determine the prevalence of the epidemic and pandemic influenza, the hospitalization and mortality rates in children each year. Surveillance of the circulation of different influenza virus strains is important in ensuring a good strain con-cordance for the composition of the annual influenza vaccine. The Global Influenza Hospital Surveillance Network® (GIHS...
Source: Mikrobiyoloji Bulteni - Category: Microbiology Tags: Mikrobiyol Bul Source Type: research
PMID: 32564928 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Ann Allergy Asthma Immunol Source Type: research
Before the ravaging appearance of the severe acute respiratory syndrome coronavirus 2, influenza viruses have been among the major players in the history of health disasters over the past century.1,2 Because the 1918 Spanish flu pandemic claimed more than 50 million lives followed by annual resurgence of varying degrees of morbidity and mortality, the influenza vaccine program has driven platform development and global collaborative surveillance networks. These networks support the definition of antigenic shifts that drive annual vaccine specificities for manufacturing responses.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research
Nearly a year ago, the editors at the Annals of Allergy, Asthma&Immunology decided to put together an issue focused on vaccine technology and the importance of vaccination. At that time, we thought it was best to focus on respiratory virus vaccines (specifically for influenza and respiratory syncytial virus [RSV]), issues related to developing vaccines, and the distressing social movement against vaccination. Coronaviruses were not even considered. Now, we find ourselves in the middle of a pandemic created by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with a rush to develop...
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Editorial Source Type: research
By Joseph ChamieNEW YORK, Jun 15 2020 (IPS) While the end of life remains the inescapable fate of every man, woman and child, death can be delayed as has been demonstrated repeatedly throughout human history. Amid the current coronavirus pandemic, a paramount objective is delaying death from Covid-19 for many millions of people across the globe. Yet, now approaching 500,000 Covid-19 deaths worldwide and many more expected before a vaccine becomes available, the objective of delaying deaths due to the novel coronavirus is far from being realized. Greater efforts are clearly required to contain the pandemic’s spread an...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Global Headlines Health TerraViva United Nations Source Type: news
ntilde;ez Margüello To determine the prevalence of influenza vaccination in chronic obstructive pulmonary disease (COPD) patients and its effect on COPD exacerbations, we conducted a retrospective population-based cohort study analyzing real-life data. We included all registered COPD patients ≥40 years old using respiratory medication during the study period (2012–2013). Influenza vaccination during the 2012/2013 campaign was the parameter studied. Moderate and severe exacerbations during 2013 were the dependent outcome variables. Logistic regression adjusting for age, gender, concomitant asthma d...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
We present a case of an immunodeficient patient patient who has recovered from COVID-19 infection. This is a 53-year-old female with Common Variable Immunodeficiency diagnosed in 1996 and has been on regular IVIG replacement therapy, GAMUNEX ®-C 40 grams (520 mg/ kg/ dose) every 2 weeks. Last IgG trough level was 1478 mg/dl on 11-12-19. High dose influenza vaccine administered in September 2019. The patient has also hypothyroidism, bronchiectasis, and Sjogren’s Syndrome treated with hydroxychloroquine 400 mg daily.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research
We present a case of a patient with immunodeficiency who has recovered from coronavirus disease 2019 (COVID-19). The patient is a 53-year-old woman who received a diagnosis of common variable immunodeficiency in 1996 and has been on regular intravenous immunoglobulin (IVIG) replacement therapy with Gamunex-C 40 g (520 mg/kg/dose) every 2 weeks. The last immunoglobulin G trough level was 1478 mg/dL on November 12, 2019, and a high-dose influenza vaccine was administered in September 2019. The patient also has hypothyroidism, bronchiectasis, and Sjogren's syndrome treated with hydroxychloroquine 400 mg daily.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research
More News: Asthma | Children | Education | Emergency Medicine | Influenza | Influenza Vaccine | Medicaid | Primary Care | Respiratory Medicine | Universities & Medical Training | Vaccines